FDA-Inspected Site

Angiodynamics, Inc.

9 FDA inspections are on record for Angiodynamics, Inc. in Queensbury, United States.

483· Form 483 issued

Queensbury, United States · Last updated July 10, 2026

Overview

  • 9 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-01-10.

At a glance

Inspections

9

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Jan 2025 – 10 Jan 2025Medical Devices & Rad Health483View 483 →
4 Apr 2016 – 21 Apr 2016Medical Devices & Rad Health483View 483 →
14 Jan 2014 – 4 Feb 2014Medical Devices & Rad Health483View 483 →
24 Sep 2012Not recorded483On file
10 Feb 2012Not recorded483View 483 →
13 Jan 2011Not recorded483View 483 →
16 Dec 2009Not recorded483View 483 →
12 Jun 2008Not recordedClean
5 Jun 2003Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

10 Jan 2025
21 CFR 820.198(a)

Lack of or inadequate complaint procedures

Cited by Wendy M Stone

10 Jan 2025
21 CFR 820.198(e)

Records of complaint investigation

Cited by Wendy M Stone

21 Apr 2016
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Jacqueline S Warner

21 Apr 2016
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Jacqueline S Warner

21 Apr 2016
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Jacqueline S Warner

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations3x
21 CFR 820.198(a)Cited across public-safe Form 483 observations3x
21 CFR 820.30(c)Cited across public-safe Form 483 observations3x
21 CFR 803.17Cited across public-safe Form 483 observations2x
21 CFR 803.17(a)(1)Cited across public-safe Form 483 observations2x
21 CFR 806.10(a)(1)Cited across public-safe Form 483 observations2x
21 CFR 820.160(a)Cited across public-safe Form 483 observations2x
21 CFR 820.180Cited across public-safe Form 483 observations2x
21 CFR 820.184Cited across public-safe Form 483 observations2x
21 CFR 820.198(b)Cited across public-safe Form 483 observations2x
21 CFR 820.30(g)Cited across public-safe Form 483 observations2x
21 CFR 820.70(a)Cited across public-safe Form 483 observations2x
21 CFR 803.50(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 806.10(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 820.120Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.198(c)Cited across public-safe Form 483 observations1x
21 CFR 820.198(e)Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(d)Cited across public-safe Form 483 observations1x
21 CFR 820.30(h)Cited across public-safe Form 483 observations1x
21 CFR 820.70(c)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(a)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Angiodynamics, Inc.'s 7 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat